Keyphrases
Administrative Registers
12%
Appropriate Treatment
12%
Cardiovascular Morbidity
12%
Cardiovascular Mortality
50%
Cardiovascular Risk
100%
Case-crossover
12%
Cause-specific
100%
Comorbidity
12%
Concomitant Medications
12%
Confidence Interval
50%
Coronary Heart Disease Mortality
12%
Cox Proportional Hazard Analysis
12%
Cyclooxygenase-2 Inhibitors
12%
Danish Population
12%
Diclofenac
25%
Dose Effect
12%
Drug Therapy
12%
Fatal Stroke
25%
Healthy Individuals
100%
Hospitalization
12%
Increasing Risk
12%
Naproxen
25%
National Cohort Study
12%
Non-associated
12%
Non-selective
12%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Nonfatal Myocardial Infarction
12%
Nonfatal Stroke
25%
Odds Ratio
50%
Pharmacotherapy
12%
Population Aging
12%
Prescription Claims
12%
Prescription Drugs
12%
Rofecoxib
25%
Selection Criteria
12%
Medicine and Dentistry
Apoplexy
25%
Cardiovascular Mortality
12%
Cardiovascular Risk
100%
Cardiovascular System
62%
Comorbidity
12%
Cyclooxygenase 2 Inhibitor
12%
Diclofenac
25%
Drug Prescription
12%
Drug Therapy
25%
Gene Linkage
12%
Ibuprofen
12%
Myocardial Infarction
12%
Naproxen
25%
Nonsteroid Antiinflammatory Agent
100%
Odds Ratio
50%
Proportional Hazards Model
12%
Rofecoxib
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Mortality
12%
Cardiovascular Risk
100%
Cerebrovascular Accident
25%
Comorbidity
12%
COX-2 Inhibitor
12%
Diclofenac
25%
Heart Infarction
12%
Ibuprofen
12%
Naproxen
25%
Non-Steroidal Anti-Inflammatory Drug
100%
Pharmacotherapy
25%
Rofecoxib
25%